Moves in pharma app market, but user longevity an issue
August 28, 2015Medical Communications Communication, apps, digital, medcomms, medical communications, mobile
Pharma companies continue to invest in the mobile app market, but studies have found that pharma apps suffer the same …
NHS looks to ESC for next-gen heart drug data
August 28, 2015Medical Communications, Research and Development ALN-PCScs, Repatha, alirocumab, cardiology, cardiovascular disease, cvd, evolocumab, heart disease, high cholesterol, praluent
New data is expected to be presented at the European Cardiology Society congress in London, on the high cholesterol drugs …
Novo Nordisk to buy two pharma research companies
August 27, 2015Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, mergers and acquisitions
Novo Nordisk is to acquire two privately-held biopharmaceutical research companies specialising in diabetes, for undisclosed sums. Calibrium and MB2, formed …
Abbott to table $25bn bid for medical device maker St Jude?
August 27, 2015Manufacturing and Production, Sales and Marketing Abbott Laboratories, mergers and acquisitions, st jude medical
Abbott Laboratories is said to be preparing a $25 billion takeover bid for medical device maker St Jude Medical. Illinois-based Abbott …
Cally Clarkson joins GCI Health as first director of medical education
August 27, 2015Medical Communications Cally Clarkson, GCI Health
GCI Health has appointed Cally Clarkson as its first ever director of medical education. Cally is based in GCI Health’s …
Vicky Smith promoted to senior account executive at Liberation Unlimited
August 27, 2015Medical Communications Vicki Smith, liberation unlimited
Liberation Unlimited has promoted Vicky Smith to senior account executive.Vicky joined Liberation Unlimited in 2013, and has since played an …
Alvogen buys four-drug portfolio from Pfizer
August 27, 2015Sales and Marketing Alvogen, Pfizer
Alvogen has entered into a agreement with Pfizer to purchase a portfolio of four pharmaceutical products for the US market, …
NHS restriction of CML treatment in England criticised
August 27, 2015Medical Communications, Sales and Marketing NHS, NICE, chronic myeloid leukaemia, leukaemia
Medical experts have criticised NHS cost regulators’ decision to limit the use of Ariad’s Iclusig (ponatinib) in the treatment of …
Immatics and MD Anderson launch new company to develop ACR therapies
August 27, 2015Research and Development, Sales and Marketing Cancer, MD Anderson Cancer Center, immatics, keytruda
Immatics Biotechnologies and The University of Texas MD Anderson Cancer Center (MDACC) have together launched a new company focusing on …
NICE targets tight blood sugar control in new diabetes guidelines
August 27, 2015NICE, NICE guidelines, Public Health England, Type 1 diabetes, diabetes
NICE has urged healthcare professionals to target tighter blood sugar control, in a suite of recommendation in updated guidelines on …
Lilly defeats Teva in US court over Alimta patent
August 26, 2015Research and Development, Sales and Marketing Alimta, Eli Lilly, Teva Pharmaceutical, lung cancer
Eli Lilly has won a case in a US federal court, in a battle over Teva’s attempt to create a …
Novo Nordisk plans $2bn expansion of production facilities
August 26, 2015Manufacturing and Production, Research and Development Novo Nordisk, manufacturing
Novo Nordisk will invest an estimated $2 billion over the next five years in new production facilities in the US, …
After the legal case – where next for pharma industry transparency?
August 26, 2015Research and Development clinical trial transparency, clinical trials, health research authority, transparency
Even in an industry as litigious as pharma can sometimes be, the recent legal drama that has played out in …
Novo Nordisk abandons Victoza submission after mixed T1D results
August 26, 2015Research and Development Novo Nordisk, Victoza, diabetes, insulin
Novo Nordisk has been forced to scrap plans to expand its licence for Victoza to include adults with type 1 …
Researchers hopeful experimental antiviral treatment stops Ebola
August 26, 2015Research and Development Ebola, Ebola virus, Ebola virus disease, Toyama Chemical, VSV-ZEBOV, favipiravir, zmapp
An experimental antiviral therapy may have prevented British healthcare workers from contracting Ebola after exposure to the disease in West …
Lilly and Boehringer launch biosimilar insulin in the UK
August 26, 2015Manufacturing and Production, Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Eli Lilly, Lantus, abasaglar, basal insulin, biosimilar, biosimilars, diabetes, insuling glargine, lilly
Lilly and Boehringer Ingelheim have launched their biosimilar insulin, called abasaglar, for the UK market. Abasaglar will now challenge the …
TSRI and Janssen close in on universal flu vaccine
August 25, 2015Manufacturing and Production Janssen, Vaccine, flu, immunology, universal flu vaccine
Scientists from Janssen and The Scripps Research Institute (TSRI) have found a way to induce antibodies to fight a wide …
Allergan recalls eye drugs after complaints of blurred vision
August 25, 2015Manufacturing and Production Allergan, manufacturing, product recalls, production, recalls
Allergan has issued a recall for batches of eye ointments sold in the US, after customers complained of foreign bodies …
Takeda in Velcade patent blow
August 25, 2015Manufacturing and Production Actavis, Sandoz, Takeda, Velcade, bortezomib, ixazomib
Takeda has lost a court case contesting the patent for its blockbuster multiple myeloma drug Velcade, in a decision that …
AZ appoints Genentech’s Sean Bohen as chief medical officer
August 25, 2015Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Briggs Morrison, Sean Bohen
AstraZeneca has appointed Dr Sean Bohen as executive vice president of global medicines development and chief medical officer.Dr Bohen will …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
